Very High HIV Incidence and Associated Risk Factors in a Longitudinal Cohort Study of Diverse Adolescent and Young Adult Men Who Have Sex with Men and Transgender Women
To report HIV incidence and associated factors among young men who have sex with men (YMSM) and transgender women (TW). Data were collected February 2015 to July 2018 in the RADAR longitudinal cohort study of YMSM/TW aged 16–29 years (N = 1093). Data included tests for HIV and rectal STIs and self-reported sexual behaviors and networks characteristics. HIV incidence rates were 2.91 per 100 person years (44 seroconversions among 1513 person years). Incidence was significantly higher in Black participants than white (IRR 8.81; 95% CI 2.72–45.26) and Latinx (IRR 3.15; 1.49–7.28) participants, but no significant differences by gender identity were found. Testing positive for rectal STIs (HR 2.50; 95% CI 1.27–4.92) and sex with a partner from a high HIV incidence community area (HR 2.46; 95% CI 1.19–5.07) were associated with higher incidence. HIV incidence was very high and Black YMSM/TW experienced higher HIV incidence attributable to partner race and geographic residence. Rectal STIs were associated with increased HIV incidence.
KeywordsHIV incidence Gay and bisexual men Young MSM Transgender women Adolescent
This study was funded by the National Institute on Drug Abuse (U01DA036939). We acknowledge the support of the Third Coast Center for AIDS Research (P30AI117943) and the Northwestern University Clinical and Translational Sciences Institute (UL1TR001422). We thank the participants in the RADAR study for sharing their experiences. We acknowledge the contributions of the RADAR study staff, particularly Antonia Clifford, Justin Franz, Roky Truong, Christian Castro, and Hannah Hudson.
This study was funded by the National Institute on Drug Abuse (U01DA036939).
Compliance with Ethical Standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
- 1.Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV surveillance supplemental report web site. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published 2018. Accessed 21 Sep 2018.
- 21.Innovacon Inc. Drugs of abuse: one step drug screen test card: instruction sheet for single and multi drug screen test cards for any combination of the following drugs: AMP/BAR/BZO/COC/THC/MTD/mAMP/MDMA/MOP/OPI/OXY/PCP/PPX/TCA. In. San Diego, CA: CLIAwaived.com; n.d.Google Scholar
- 22.Substance abuse and mental health services administration. Clinical drug testing in primary care. In. 32 ed. Rockville, MD: Subst Abuse Mental Health Serv Adm.; 2012.Google Scholar
- 24.Centers for disease control and prevention and association of public health laboratories. Technical update on HIV-1/2 differentiation assays. https://stacks.cdc.gov/view/cdc/40790. Published 2016. Accessed 11 Apr 2017.
- 28.Chicago Department of Public Health. HIV/STI surveillance report 2016. Chicago, IL2016.Google Scholar
- 29.World Health Organization and UNAIDS. Technical update on HIV incidence assays for surveillance and monitoring purposes: WHO HIV Incidence Assay Working Group Meeting. Barecelona, Spain: UNAIDS; 2015.Google Scholar
- 30.South African centre for epidemiological modeling and analysis: incidence estimation tools. http://www.incidence-estimation.org/page/tools. Published 2015. Accessed 3 Oct 2018.